Skip to main content
ANZSVS Conference 2024
Times are shown in your local time zone GMT
Speaker Profile Image

Andrew Bradbury


Professional Bio

Professor Andrew Bradbury took up post as the Sampson Gamgee Professor of Vascular Surgery at the University of Birmingham (UoB), and as an Honorary Consultant Vascular Surgeon at the Heart of England (now University Hospitals Birmingham) NHS Foundation Trust, in January 2000, having previously worked as a Senior Lecturer and Consultant Surgeon at the University of Edinburgh since 1995, following training in General and Vascular Surgery in Scotland and London. From 2005 to 2010, Andrew was the Education Dean responsible for running the MB ChB and all the other clinical programmes within the College of Medical and Dental Sciences at UoB. During that period, Andrew completed an MBA at the Birmingham Business School at UoB. Between 2015 and 2022, Andrew was Chair of the UK National Institute of Health Research (NIHR) Health Technology Assessment (HTA) research programme Hospital-based Care Committee, and was also a member of the NIHR HTA Programme Oversight Committee, reporting to the Director. Andrew co-authored the UK National Institute for Health and Care Excellence (NICE) national guidelines on Peripheral Arterial Disease (PAD) (2012) and on Varicose Veins and Leg Ulcers (2013), and also chaired the NICE Abdominal Aortic Aneurysm (AAA) national Guideline Committee (GC) (2015-2020). Andrew has published over 250 articles in peer review journals and authored numerous book chapters. Recent publication highlights include the UK NIHR HTA funded EndoVenous Reflux Ablation (EVRA) trial results in the NEJM (2018), the Global Vascular Guidelines (GVG) on Chronic Limb Threatening Ischaemia (CLTI) in the JVS and EJVES (2019), and UK NIHR HTA funded Graduated compression stockings as an Adjuvant to Pharmaco-prophylaxis in elective Surgical patients (GAPS) trial in the BMJ (2020). Andrew is Chief Investigator and grant-holder for the UK NIHR HTA funded BASIL-1, 2 and 3 trials. The BASIL-2 results were published in The Lancet in April 2023. Andrew expects to be able to publish the BASIL-3 results in a high impact journal towards the end of 2023. Andrew retired from National Health Service (NHS) and private clinical practice at the end of 2022 but is still working part-time for the UoB in order to complete the BASIL-2 and -3 trials, and to see through various other academic commitments. Andrew has been awarded Emeritus Professor status by the UoB from the end of 2024.